CareDx and Johns Hopkins Partner on AlloSure Lung Surveillance
With the COVID 19 pandemic, there has been an emergent need to implement patient home isolation to reduce the risk of community spread and exposure to the dangerous virus. For high-risk populations who need close medical monitoring,
“Lung transplant patients are at the highest risk of infections and rejection, so they need close monitoring and care. We are glad to partner with
“CareDx has offered AlloSure to the lung transplant population as compassionate use, and we are now seeing the broader need with RemoTraC during these unique times,” said
Chief Marketing Officer
Source: CareDx, Inc.